Read More

HeartBeam Announces FDA Submission Of HeartBeam AIMI Product

Submission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market 18+ million People in the US have Coronary Artery DiseaseSubmission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market

BEAT